Le Lézard
Classified in: Science and technology
Subjects: Conference, Event

ATT&CKcon 4.0 to Celebrate 10th Anniversary of MITRE ATT&CK® with Content & Networking for Cyber Defenders


Celebrating the 10th anniversary of MITRE ATT&CK®, ATT&CKcon 4.0 will help users leverage the cybersecurity framework and level up their threat-informed defense, while also providing time to build personal connections with other cyber defenders and the MITRE ATT&CK team.

Running October 24-25 at MITRE's headquarters in McLean, Va., ATT&CKcon features content and networking geared for cyber leaders and practitioners across the workforce spectrum, whether they are just beginning a cybersecurity career or looking to strengthen capabilities and deepen engagement with the MITRE ATT&CK community.

"Since MITRE ATT&CK started in 2013, it has become the common language for threat actor analysis, and we're continually improving it and expanding its knowledge base," said Wen Masters, vice president of cyber technologies, MITRE. "We're advancing the worldwide community of cyber defenders by empowering them with vital information to thwart network intruders and safeguard data. ATT&CKcon attendees learn from the conference programming and from each other through in-depth conversations on how to best incorporate MITRE ATT&CK into their own cyber operations."

Keynoter Runa Sandvik, the founder of Granitt, leads off the conference. Sandvik helps journalists and other at-risk professionals work securely around the world.

As part of the anniversary celebration, a panel of MITRE ATT&CK's original creators and alumni will discuss how the framework began and evolved. Another 17 sessions cover content such as:

Plus, James Stanley, chief of product development, Cybersecurity and Infrastructure Security Agency (CISA), will discuss how CISA has adopted MITRE ATT&CK, incorporating it into the agency's cybersecurity advisories.

ATT&CKcon also is accepting speaker applications for five-minute lightning talks on how users are using MITRE ATT&CK in their threat-informed defense. The application link is sent to in-person attendees only.

In-person registration is now open, and virtual registration opens September 26.

Current sponsors include Analyst1, Ardalyst, Cyware, Interpres, OpenText, Pentera, Prelude, SafeBreach, Third Wave Innovations, and VECTR. Some sponsorships are still available. Contact [email protected] for additional sponsorship opportunities.

About MITRE

MITRE's mission-driven teams are dedicated to solving problems for a safer world. Through our public-private partnerships and federally funded R&D centers, we work across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation. Learn more at mitre.org.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: